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Background: Fast track recovery is a care process goal after cardiac surgery. Intraoperative anesthetic depth may
impact recovery, but the impact of brain monitoring on time to extubation and intensive care unit (ICU) length of
stay after cardiac surgery has not been extensively studied. Our goal was to determine if BIS-guided anesthesia
improves time to extubation compared to MAC-guided anesthesia in a cardiac surgery population.
Methods: In this secondary outcome analysis of a randomized controlled study, we analyzed 294 patients
undergoing elective coronary bypass grafting, valve replacements, and bypass plus valve replacements at a single
tertiary referral center between February 1, 2009 and April 30, 2010. We analyzed cardiac surgery patients that had
been randomized to BIS-guided anesthesia alerts (n = 131) or MAC-guided anesthesia alerts (n = 163). The primary
outcome measure was time to extubation in the BIS-guided and anesthetic concentration-guided groups.
Secondary outcomes were length of stay in the ICU and total postoperative hospital length of stay.
Results: Valid extubation time data were available for 247 of 294 patients. The median [IQR] time to extubation was
307 [215 to 771] minutes in the BIS group and 323 [196 to 730] minutes in the anesthetic concentration group
(p = 0.61). The median [IQR] ICU length of stay was 54 [29 to 97] hours versus 70 [44 to 99] hours (p = 0.11). In
terms of postoperative hospital length of stay, there was no difference between the groups with median [IQR]
times of 6 [5-8] days (p = 0.69) in each group.
Conclusions: The use of intraoperative BIS monitoring during cardiac surgery did not change time to extubation,
ICU length of stay or hospital length of stay. Data regarding BIS monitoring and recovery in an exclusively cardiac
surgery population are consistent with recent effectiveness studies in the general surgical population.
Trial registration: ClinicalTrials.gov number NCT00689091.
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The past two decades have seen an increasing interest in
early endotracheal extubation after cardiac surgery, typ-
ically defined as extubation within 8 hours of the end of
surgery. Early extubation is associated with decreased in-
tensive care unit (ICU) length of stay (LOS), hospital
LOS, and thus the potential for improved recovery and
decreased resource utilization [1,2]. Risk factors for pro-
longed intubation include need for inotropic support,
excessive bleeding, and atrial arrhythmias; these factors* Correspondence: dwoodrum@med.umich.edu
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Early extubation has been shown to be safe compared to
standard post-cardiac surgery extubation [2,4,5]. While
intraoperative anesthetic techniques have evolved to
emphasize fast track recovery [6], the role of brain mon-
itoring in extubation and length of stays after cardiac
surgery has not been well studied. In the B-Aware [6],
B-Unaware [7], and BAG-RECALL [8] trials, the use of
BIS monitoring was not associated with a reduction in
the amount of anesthesia administered or a decreased
hospital length of stay, but only some of the patients in
these trials underwent cardiac procedures.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CO, USA) has been used as a surrogate for depth of
anesthesia in and has also been posited to improve re-
covery from surgery and general anesthesia. The BIS
monitor could have direct or indirect effects on recov-
ery. In terms of direct effects, initial efficacy studies have
demonstrated that BIS monitoring can reduce anesthetic
use and, consequently, the time to extubation and other
recovery parameters in noncardiac surgery [9,10]. In
other words, consciousness recovers faster by using less
anesthetic. However, BIS monitoring could also have indir-
ect effects on recovery across different surgical popula-
tions. Such effects could be mediated through cognitive
phenotypes that might play a more important role in de-
termining extubation in an ICU setting. For example, a pa-
tient with delirium in the ICU may be less likely to be
extubated. Thus, if the intraoperative use of the BIS moni-
tor affects intermediate cognitive phenotypes such as post-
operative delirium, it could alter the time to extubation in
the postoperative period of critical care. Indeed, a recent
study reported on the protective odds ratio conferred by
BIS-guided anesthesia when studying postoperative de-
lirium in cardiac surgical patients [11]. In a recent study
of noncardiac patients, it was shown that BIS-guided
anesthesia was associated with a reduction in the concen-
tration of anesthetics delivered, with improvements in
cognition at three months after surgery [12]. Thus, the in-
traoperative use of the BIS monitor has been linked to a
number of outcomes that extend far into the postoperative
period. As such, we hypothesized that the use of the BIS
monitor during cardiac surgery could also have relevance
to the postoperative period in terms of reducing recovery
times. The primary aim of this study was to determine
whether the intraoperative use of the BIS improved
time to extubation after cardiac surgery compared to
an anesthetic concentration protocol. Secondary outcomes
included differences in length of stay in the intensive care
unit and total postoperative length of stay in the hospital.
Methods
Study design and patient cohort
The Michigan Awareness Control Study (MACS; Clinical-
Trials.gov Trial Registration Number NCT00689091) was
a randomized controlled effectiveness trial comparing
alerting protocols based on the BIS (trigger for BIS > 60)
and anesthetic concentrations (minimum alveolar concen-
tration [MAC] <0.5). The trial included adults undergoing
general anesthesia for an unselected surgical population.
The major conclusion of MACS was that there was no de-
tectable difference in the incidence of definite awareness
or recovery variables between monitoring protocols based
on either BIS values or anesthetic concentration [13]. The
current study is a secondary analysis of cardiac patients
from this cohort and ethical approval (HUM00044647)was provided by the Institutional Review Board of the
University of Michigan, Ann Arbor, USA (Chairperson
Michael Geisser) on 26 September 2011. Patient consent
was waived as this was a secondary analysis of de-identified
data. Eligible patients included all elective coronary bypass
grafting (CABG), valve replacements, and CABG plus valve
replacements that were part of the primary study lasting
from February 1, 2009 until April 30, 2010. Time during re-
cruitment differs from the parent study because recruitment
of patients at the Cardiovascular Center of the University of
Michigan Health System began later than other study sites.
Exclusion criteria included emergency cases, aortic dissec-
tions, or hypothermic circulatory arrest cases, since these
cases are typically not candidates for early extubation.
Perioperative data were collected using Centricity®
(General Electric Healthcare, Waukesha, WI, USA), an
anesthesia information management system. All infor-
mation is entered by anesthesia personnel (residents,
fellows, nurse anesthetists and attendings). For each
data point, the user may select from a predefined list or
enter free-text information to describe any clinical vari-
able. A history and physical examination is electronic-
ally documented for every case. Additional information
was obtained from the Society of Thoracic Surgeons
(STS) National Cardiac Database. The database collects
more than 350 variables from approximately 95 percent
of all adult cardiac surgery centers throughout the
United States. Each site voluntarily enters patient data
using pre-specified definitions and certified software
systems; the data are sent semiannually to the STS Data
Warehouse and Analysis Center at the Duke Clinical
Research Institute. The data subsequently undergo a
series of quality checks before being included in the na-
tional sample.
Surgical procedures
Patients underwent surgery either via a median sternot-
omy or via a thoracotomy (for redo mitral valve opera-
tions or patients’ cosmetic-driven request). All cases
were performed using cardiopulmonary bypass (CPB),
with antegrade and/or retrograde cardioplegia for myo-
cardial protection. CPB utilized nonpulsatile flow for all
cases. Heparin was administered to achieve and main-
tain an activated clotting time >450s. Both nasal and
bladder temperature probes were placed for monitoring,
and the patient’s temperature was reduced to between
32-35°C during CPB. After termination of CPB, protam-
ine 1–1.3 mg/100 units heparin was administered. All
patients were transported to the ICU intubated once
hemodynamically stable.
Anesthetic technique and interventions
Induction of anesthesia was performed with midazolam,
fentanyl, pancuronium, with or without propofol or
Table 1 Patient characteristics
MAC (N = 163) BIS (N = 131) P Value Odds ratio 95% CI
Male 102 (62.6%) 92 (70.2%) 0.169 1.41 0.86 to 2.30
Body mass index (median) 28.7 28.0 0.411
Age (median) 63.0 64.0 0.824
Preoperative β-blockers 99 (60.7%) 93 (71.0%) 0.66 1.58 0.97 to 1.88
Current smoker 11 (6.7%) 10 (7.6%) 0.77 1.14 0.47 to 2.78
Former smoker 68 (41.7%) 64 (48.9%) 0.221 1.34 0.84 to 2.12
Chronic pain 17 (10.4%) 7 (5.3%) 0.113 0.49 0.20 to 1.21
Stroke/transient ischemic attack 11 (6.7%) 8 (6.1%) 0.824 0.90 0.35 to 2.30
Diabetes mellitus 48 (29.4%) 30 (22.9%) 0.206 0.71 0.42 to 1.21
Renal failure 25 (15.3%) 33 (22.9%) 0.098 1.64 0.91 to 2.96
Asthma 10 (6.3%) 8 (6.2%) 0.986 0.99 0.38 to 2.60
Sleep apnea 50 (30.9%) 34 (26.2%) 0.377 0.79 0.48 to 1.33
w/ CPAP 16 (9.8%) 14 (10.7%) 0.806 1.10 0.52 to 2.34
Lung disease 109 (66.9%) 89 (67.9%) 0.846 1.05 0.64 to 1.72
Dyspnea 101 (62.0%) 83 (63.4%) 0.806 1.06 0.66 to 1.71
Pulmonary hypertension 16 (9.8%) 14 (10.7%) 0.806 1.10 0.52 to 2.34
Chronic obstructive pulmonary disease 14 (8.4%) 13 (9.2%) 0.971
Other lung disease 7 (4.3%) 11 (8.4%) 0.145 2.04 0.77 to 5.43
Cardiovascular disease 153 (93.9%) 125 (95.4%) 0.559 1.36 0.48 to 3.85
Valvular heart disease 94 (57.7%) 73 (55.7%) 0.738 0.92 0.58 to 1.47
Coronary artery disease 80 (49.1%) 73 (55.7%) 0.257 1.31 0.82 to 2.07
Congestive heart failure 42 (25.8%) 32 (24.4%) 0.793 0.93 0.55 to 1.58
Dysrhythmia 37 (22.7%) 31 (23.7%) 0.845 1.06 0.61 to 1.82
Angina 35 (21.5%) 33 (25.2%) 0.452 1.23 0.71 to 2.12
Myocardial infarction 30 (18.4%) 28 (21.4%) 0.525 1.21 0.68 to 2.14
Orthopnea 14 (8.6%) 5 (3.8%) 0.098 0.42 0.15 to 1.21
Peripheral vascular disease 6 (3.7%) 9 (6.9%) 0.217 1.93 0.67 to 5.57
Endocarditis 6 (3.7%) 6 (4.6%) 0.699 1.26 0.40 to 3.99
Ejection fraction
<30 11 (6.7%) 10 (7.8%) 0.947*
30-50 37 (22.7%) 29 (22.5%)
>50 115 (70.6%) 90 (69.8%)
Airway
Previous difficult intubation 0 0 0
Limited mouth opening 3 (1.8%) 5 (3.8%) 0.301 2.12 0.50 to 9.02
Limited thyromental distance 12 (7.4%) 8 (6.1%) 0.671 0.82 0.32 to 2.07
Limited neck flexion 1 (0.6%) 2 (1.4%) 0.627
Limited neck extension 16 (9.6%) 14 (9.9%) 0.627
Limited jaw protrusion 18 (11.0%) 11 (8.4%) 0.335
Intraoperative view grade 3 or 4 8 (5.0%) 3 (2.4%) 0.254
Intraoperative mask grade 3 or 4 6 (3.7%) 5 (3.8%) 0.960
MAC minimum alveolar concentration, BIS Bispectral index, CI confidence intervals.
*Ejection Fraction is an ordinal variable with three categories as listed above. There was no significant difference between the MAC and BIS patients across the
three ordinal categories.
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Table 2 Recovery parameters
Bispectral index Minimum alveolar concentration p value
Time to extubation (min) 307 [215 to 771] 323 [196 to 730] 0.610
Intensive care unit length of stay (hrs) 54 [29 to 97] 70 [44 to 99] 0.108
Hospital length of stay (days) 6.0 [5.0-8.0] 6.0 [5.0-8.0] 0.688
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relaxation. Anesthesia was subsequently maintained with
isoflurane, and additional fentanyl and pancuronium as
needed. Isoflurane was continued during cardiopulmonary
bypass. All patients were sedated with propofol infusions
at varying rates at the end of the case; sedation was con-
tinued in the ICU until the patients were weaned for tra-
cheal extubation.
In the Michigan Awareness Control Study, patients were
randomized to a BIS-guided group or MAC-guided group.
Automated pages were sent to the intraoperative anesthesia
provider when the median BIS rose above 60 for a 5-
minute epoch or when the effective age-adjusted MAC fell
below 0.5 (in the MAC-guided group). There was no lower
value alert for the BIS group and no upper value alert for
the MAC-guided group.
Outcomes
The primary outcome measure for the current study was
the time to extubation across the two groups (BIS-guided,
MAC-guided). Secondary outcomes included length of stay
in the ICU and total postoperative length of stay in the hos-
pital. We also compared the groups in terms of factors that
could impede early extubation, including vasopressor usage
at the end of the case and excessive bleeding, for which we
used intraoperative blood product usage as a surrogate. We
defined high blood product utilization as greater than 3
units of fresh frozen plasma (FFP) or greater than 4 units of
packed red blood cells (pRBCs). We arrived at these values
based on previous studies of average blood utilization in
cardiac surgery [14-16].
Statistical analysis
Statistical analysis was performed using SPSS statistics ver-
sion 19 (IBM Corp, Somers, NY, USA). Data from the
anesthesia information system and the STS database from
our institution were merged together for all patients that
met the inclusion criteria using a third-party honest broker
system. After the merge was completed, all identifiers wereTable 3 Intraoperative high blood product utilization
BIS MAC
High blood product utilization 25 (19.1%) 28 (17.2%
Intraoperative FFP >3 units 13 (9.9%) 10 (6.1%)
Intraoperative pRBCs >4 units 22 (16.8%) 27 (16.6%
High Blood Product Utilization defined as: >3 units fresh frozen plasma (FFP) or >4removed prior to analysis by the study team. Patients with-
out valid data in both the anesthesia information system
and the STS database were excluded from this analysis.
The Kolmogorov-Smirnov statistic was used to determine
normality for all continuous data elements. If the p-value
was significant (<0.05), the assumption of normality was
violated and a non-parametric test (Mann Whitney U test)
was used. For categorical variables, a two-tailed Pearson
chi-square or Fisher’s Exact test were used as appropriate.
A p-value of <0.05 was considered statistically significant.
Results
Data were captured for a total of 294 patients divided
into two groups: those with MAC-based alerts (163 pa-
tients) and those with BIS-based alerts (131 patients).
The two groups were well matched with respect to age,
sex, body mass index, smoking history, airway characteris-
tics, as well as the number and severity of comorbidities
such as cardiac, pulmonary, and renal disease (Table 1).
In terms of time to extubation, the primary outcome,
there was no statistically significant difference between
the two groups (Table 2). Of the 294 patients, valid extu-
bation time data were available for 247 patients. The
median [inter quartile range (IQR)] times to extubation
in the BIS-based alert and MAC-based alert groups were
307 [215 to 771] and 323 [196 to 730] minutes, respect-
ively; p = 0.610 (Table 2). There was also no statistically
significant difference in the secondary outcome of ICU
length of stay. The median [IQR] length of stay was 54
[29 to 97] hours versus 70 [44 to 99] hours; p = 0.108
(Table 2). Finally, there was no difference between the
groups for the secondary outcome of total postoperative
hospital length of stay with median [IQR] times of 6
[5-8] days in each group; p = 0.688 (Table 2).
There are many factors that can prolong postoperative
intubation following cardiac procedures, including: pres-
ence of an intra-aortic balloon pump (IABP), excessive
bleeding, vasopressor use, pre-existing lung disease, pro-
longed surgical time, or excessive depth of anesthesia [4].p value Odds ratio 95% CI
) 0.673 1.14 0.63 to 2.10
0.229 1.69 0.71 to 3.98
) 0.958 1.02 0.55 to 1.88
units packed red blood cells (pRBCs) intraoperatively.
Table 4 Total anesthesia time
Bispectral index Minimum alveolar concentration P value
Total time under anesthesia (minutes) 363 [304 to 445] 346 [290 to 413] 0.165
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an intra-aortic balloon pump was an exclusion criterion.
There were no significant differences between the groups
in terms of lung disease (Table 1). The two groups had no
significant differences in either the FFP or pRBC use cat-
egories (Table 3). There was also no difference in total op-
erating room time (as measured by total anesthesia time)
[Table 4], or vasopressor use at the end of the case (as
measured by defined dosages prior to transport) [Table 5].
In terms of any effect of anesthetic depth on time to
extubation, the median age-adjusted MAC was not signifi-
cantly different between the BIS-based alert and MAC-
based alert groups: 0.45 [0.37 to 0.56] versus 0.46 [0.37 to
0.56]; p = 0.738. The median BIS values between the BIS-
alert and MAC-alert groups were 40 [37–42] versus 42
[38–45]; p = 0.026. This statistically significant difference is
highly unlikely to be of clinical significance, since the typical
range of BIS values consistent with general anesthesia is
40–60; note also that the BIS values were not visible to the
MAC allocation group.
Discussion
This study did not identify a statistically significant dif-
ference in time to extubation after cardiac surgery be-
tween BIS-guided and MAC-guided groups, which were
well matched in terms of comorbidities. There were also
no statistically significant differences in ICU or total
postoperative hospital lengths of stay.
In non-cardiac surgery patients, initial efficacy studies
suggested that BIS-monitoring may decrease time to
extubation [9,10]. However, subsequent analysis [17] of
large effectiveness studies did not show that BIS confers
a benefit in overall time to recovery. Time to extubation
following cardiac surgery has been an area of research
in many studies, but few involve brain monitoring.
Ender, et al. [4] have described how the implementation
of goal-focused processes (creation of a specific cardiac-
recovery post-anesthesia care unit (PACU) and modify-
ing intraoperative anesthesia) can greatly decrease time
to extubation in selected patients (stable hemodynamics
without inotropic support, no excessive bleeding, and nor-
mothermia). Gooi et al. [18] showed that the preoperative
identification of a lower-risk patient cohort allowed forTable 5 High vasopressor requirements
BIS
High vasopressor requirements (number of patients and % of total) 33
High vasopressor requirement defined as the dose of vasopressor needed within 15
kg/min, phenylephrine >40 mcg/min, vasopressin >2 units/min, epinephrine >0.02earlier extubation in that fast-track group. However, nei-
ther study utilized brain monitoring.
Wong, et al. [3] showed that increased age, female sex,
use of inotropes, excessive bleeding, atrial arrhythmias,
and presence of an intra-aortic balloon pump were associ-
ated with increased times to extubation. These variables
represent potential confounders, but the groups in our
study showed no difference in age, sex, vasopressor use,
excessive bleeding, or dysrhythmias (Table 1). Also, the
groups were similar in the median age-adjusted MAC and
total anesthesia time (Table 4) showing that the anesthetic
depth or duration had no effect on extubation times.
Although most time-to-extubation studies in cardiac
surgery patients have not included brain monitoring, a
secondary analysis by Villafranca, et al. from the BAG-
RECALL trial demonstrated that the use of a BIS protocol
during cardiac surgery in a Canadian hospital did not im-
prove extubation time compared to a protocol based on
age-adjusted 0.7 MAC [19]. A power analysis showed that
50 patients in each group would be required to detect a 30
minute difference in extubation time at a power of 0.95.
Both their study and the present investigation greatly ex-
ceed 50 patients in each cohort. The current study con-
firms the previous findings and adds to the literature by
demonstrating comparable results in a separate population
with a protocol based on an even lower MAC threshold
(age-adjusted 0.5 MAC). Thus, two independently con-
ducted analyses of larger randomized controlled trials
suggest no clear benefit to intraoperative BIS monitoring
during cardiac surgery relative to the outcome of early
extubation. Our study additionally demonstrates no differ-
ence in the secondary outcomes of ICU length of stay or
overall hospital stay. As BIS is not routinely employed in
our ICU, it cannot be concluded from the current study
whether BIS monitoring in the ICU is beneficial for earlier
extubation time.
There are limitations to this study. First, as noted, the
BIS monitor was not continued in the ICU to monitor
depth of sedation postoperatively. Furthermore, at our in-
stitution, there is no set dose and no strict protocol that
dictates depth of sedation. However, we note that a study
in which ICU propofol doses were not different between
groups, the use of a BIS monitor was not associated withMAC p value Odds ratio 95% CI
(25.2%) 35 (21.5%) 0.452 1.23 0.72 to 2.12
minutes of transport to the intensive care unit (norepinephrine >0.05 mcg/
mcg/kg/min).
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rive late in the evening are often sedated and intubated
overnight because of staffing issues when they may have
otherwise been extubated. Thus, time to extubation or ICU
length of stay are potentially skewed by these confounds.
In a previous study, it was shown that patients who were
admitted to the ICU in the evening tended to be intubated
longer independent of comorbidities and surgical factors
[18,19]. Third, this was a secondary outcome analysis of a
prospective trial with a primary outcome of intraoperative
awareness with explicit recall; data regarding recovery and
length of stay must therefore be interpreted cautiously.
However, our approach of secondary analysis eliminates
any practitioner bias of trying to achieve the outcome of
early extubation. Fourth, our anesthetic practice in car-
diac surgery does not routinely involve total intravenous
anesthesia; results may be different in this population. Fi-
nally, because the initial trial involved awareness preven-
tion, there were no lower limit alarms for BIS and upper
limit alarms for MAC, which might have altered anesthetic
management in a way that influenced time to extubation.
However, a similar secondary analysis of a BIS vs. MAC
alarm trial that incorporated both upper and lower BIS
limits similarly failed to find an association between BIS
utilization and time to extubation after cardiac surgery [19].Conclusion
There was no difference in time to extubation between
BIS-guided and MAC-guided anesthetics in a patient
population well matched for comorbidities and for po-
tential confounders for prolonged intubation. There
also were no statistically significant differences in ICU
and total post-operative hospital length of stay. Data
from the current study are impactful because they suggest
that the use of the BIS monitor during cardiac surgery does
not confer an advantage over anesthetic-concentration
guided protocols in earlier extubation times.
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